NewslettersDec 12, 2025
Porton Newsletter - November 2025 Recap
Technical Enabling Services & Solutions Company Events ESG Marketing Activities Others
News Nov 27, 2025
Porton Pharma Solutions Ranks Among China's Top 100 Premier Pharmaceutical Suppliers and Top 10 in ESG Competitiveness
Porton ranked among China's Top 100 Pharmaceutical Suppliers & ESG Competitiveness Top 10, offering global CDMO services & sustainable solutions.
News Nov 18, 2025
Porton Improves in the 2025 S&P Global ESG Score
Porton scored 50 in 2025 S&P Global Corporate Sustainability Assessment. Significant progress in energy, waste, water management, climate strategy, and supply chain. Committed to green development and sustainable operations.
NewslettersNov 05, 2025
Porton Newsletter - October 2025 Recap
Technical Enabling Services & Solutions Company Events ESG Marketing Activities Others
News Oct 20, 2025
Porton Warmly Congratulates Partner XZenith on Its Listing on the Main Board of the Hong Kong Stock Exchange
Porton congratulates XZenith on its HK listing, highlighting our CDMO partnership for innovative drug development and commercialization.
News Oct 17, 2025
Porton Unveils Porton Up 3.0 Project and Launches Quality Month Initiative, Driving Enterprise-Wide Transformation
Porton launches Porton Up 3.0 initiative at Changshou site, driving comprehensive GMP compliance, quality management, and operational excellence upgrades for CDMO partners.
NewslettersOct 10, 2025
Porton Newsletter - September 2025 Recap
Technical Enabling Services & Solutions Company Events ESG Marketing Activities Others
News Sep 28, 2025
Porton Shanghai Pudong Facility Obtained ISO 14001 and ISO 45001 Certification
Porton Pharma's Shanghai Pudong site successfully obtained ISO 14001 and ISO 45001 certifications, enhancing sustainable operations and CDMO capabilities for biotech clients.
News Sep 25, 2025
Porton Pharma Makes China's Innovative Pharmaceuticals Decennial Honor Roll, Secures 'Industry-Leading CDMO' Title
Porton Pharma honored as Industry Leading CDMO Company for innovative drug development services. Learn more about our award and global capabilities.
